Recent Episodes
Watch recent episodes on
PTV News Review
Scroll Left
Scroll Right
NicOx: The Rise of NicOx: An Interview with Damian Marron, VP Corporate Development




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: NicOx: The Rise of NicOx: An Interview with Damian Marron, VP Corporate Development
Released on: April 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 5 minute preview.
Get more information and subscribe now
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Fintan Walton talks to Damian Marron, Vice President, Corporate Development, NicOx, about the company's achievements to date - from Italian origins, it developed into a rare French biopharmaceutical success story, raising some of the largest capital sums in Europe.
  • Summary
  • Transcript
  • Participants
  • Company
Fintan Walton talks to Damian Marron, Vice President, Corporate Development, NicOx, about the company's achievements to date - from Italian origins, it developed into a rare French biopharmaceutical success story, raising some of the largest capital sums in Europe. Damian discusses NicOx's strategy with regards to attracting investors, choice of stock exchange and the rationale behind its partner selection. Also outlined are the company's objectives, ranging from its plans for the next 12 months to its long term aims regarding its conversion to a partially integrated pharmaceutical company.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Damian Marron graduated in pharmacology from the University of Liverpool in 1985, followed by post-graduate research into monoclonal antibodies at the University's Department of Radiation Oncology.

Damian has broad experience in the international pharmaceutical industry, including product and technology licensing, research and development, and sales and marketing.

Before moving to Nicox in 2002, Damian was Head of European Business Development for 3M Pharmaceuticals, which he joined in 1997.

From 1995 to 1997, Damian was UK Manager for the orphan drug group Orphan Europe, joining from Rhône-Poulenc-Rorer where he acted as Clinical Operations Manager for the Chugai-Rhône-Poulenc joint venture and Senior Clinical Research Coordinator in Oncology.

Damian worked at Glaxo from 1987 to 1992 as a Senior Clinical Research Scientist in CNS and Research Scientist in Cellular Biology.
NicOx